Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AsiDNA in combination with Olaparib in participants with recurrent solid tumors has completed; the stu…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women
A completed clinical trial evaluating whether freeze-dried table grape powder affects blood estrogen levels in postmenopausal women, in the …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effect of the Axillary Lymphatic /Vein Reflux Ratio on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer
A clinical trial update describing a study on how the axillary lymphatic/vein reflux ratio influences postoperative upper limb edema and dys…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Asprosin in Breast Cancer
A clinical trial is investigating Asprosin for breast cancer. The study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors [Phase 1, Phase 2]
This is a status update for an ongoing Phase I/II trial of XZP-3287 in metastatic solid tumors and advanced breast cancer, currently active …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors [NA]
The trial update reports that a physical activity program for Black women with breast cancer has completed, with results posted outlining it…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer [Phase 1]
A Phase 1 trial investigating TAS-116 in combination with palbociclib for advanced breast cancer and RB-deficient solid tumors has been with…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients
A clinical trial examined whether the p16 gene can predict chemotherapy-induced myelosuppression in breast cancer patients; the study has co…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting
Clinical trial update exploring how mental and cognitive health and physical activity affect perioperative outcomes in breast cancer patient…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
A clinical trial update indicates ongoing recruitment for a study using Indocyanine Green to guide selective sentinel lymph node biopsy in p…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study
This completed cohort study from West China Hospital investigates the best surgical approach for early-stage breast cancer in Chinese patien…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Vitamin D Supplementation in Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating vitamin D (cholecalciferol) supplementation in breast cancer patients is currently not recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging [NA]
This clinical trial update describes a study evaluating whether optical imaging can monitor response to neoadjuvant chemotherapy and predict…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Magseed Pro(R)/ Sentimag(R) Gen3 [NA]
The trial update shows that a study evaluating Magseed Pro and Sentimag Gen3 for breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Breast Health Education for Underserved Latino Women [NA]
A completed clinical trial evaluating a breast health education program for underserved Latino women with breast cancer. Results were posted…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
An exploratory clinical trial recruiting to develop a computational biological model based on next-generation sequencing to assess measurabl…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer [NA]
Clinical trial update on axillary lymph node dissection with vein branch reservation and its effect on postoperative upper limb edema and dy…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.
ClinicalTrials.gov entry describing a recruiting study to assess tolerability and efficacy of adjuvant ado-trastuzumab emtansine (T-DM1) in …
-
CLINICAL_TRIALS other · 2024-09-19Clinical Trial Update: Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery
A clinical trial comparing MAXIGESIC IV to Ketorolac in breast cancer surgery, focusing on seroma and hematoma rates; the study is not yet r…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Magseed Enabled Long-Term Localization of Axillary Lymph Nodes [NA]
This clinical trial update indicates that Magseed technology is being studied for long-term localization of axillary lymph nodes in breast c…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Breast Cancer Index (BCI) Registry
This document provides an update on the Breast Cancer Index (BCI) Registry trial sponsored by Biotheranostics, Inc. The trial is currently a…
-
FDA approval · 2024-09-17FDA Approved: KISQALI — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Kisqali (ribociclib) submitted by Novartis Pharmaceuticals Corporation, updating the drug's labe…
-
FDA approval · 2024-09-17FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to co-pack Kisqali (ribociclib) with Femara (letrozole) in a single package for breast cancer treatm…
-
EMA approval · 2024-09-16EMA Authorised: Bondronat (ibandronic acid) — Atnahs Pharma Netherlands B.V.
EU marketing authorisation granted to Bondronat (ibandronic acid) for hypercalcemia, breast cancer with bone metastases, and bone-related fr…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Study on Physical Activity's Relationship With Cancer and Cognition [NA]
The University of Nebraska-sponsored study on physical activity's relationship with cancer and cognition has completed.